Loading provider…
Loading provider…
Ophthalmology Physician in San Antonio, TX
NPI: 1043579733Primary Practice Location
Rashid, Rice, Flynn, & Reilly Eye Associates, PLLC
7550 I-10 W, San Antonio, TX
Primary Employer
Rashid, Rice, Flynn, & Reilly Eye Associates, PLLC
rreyes.net
HQ Phone
Get M.D. Gregory's Phone Numberphone_androidMobile
Get M.D. Gregory's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCO State Medical License
TX State Medical License
TX State Medical License
2017 - 2026
CO State Medical License
2016 - 2019

American Board of Ophthalmology
Ophthalmology
Baylor College of Medicine/Cullen Eye Institute
Residency • Ophthalmology
2013 - 2016
Houston Methodist Hospital (Medical Center)
Internship • Transitional Year
2012 - 2013
Baylor College Of Medicine
bcm.edu
Medical School
Until 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 1,227 | 1,305 |
| 2 | 92134Diagnostic imaging of retina | 453 | 515 |
| 3 | 92012Eye and medical examination for diagnosis and treatment, established patient | 415 | 707 |
| 4 | 92133Diagnostic imaging of optic nerve of eye | 227 | 229 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 215 | 220 |
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: 0.02% Betamethasone Sodium Phosphate, DRUG: 0.04% Betamethasone Sodium Phosphate
Lead Sponsor: Bausch & Lomb Incorporated
Intervention / Treatment: DEVICE: ProVisc OVD, PROCEDURE: Cataract Surgery, DEVICE: CVisc50 OVD